Amniotic Membrane Transplantation for Reconstruction of Ocular Surface Lesion Excisions in Pediatric Population

dc.authorscopusid57488058900
dc.authorscopusid23989747000
dc.authorscopusid55344634000
dc.authorscopusid6602843026
dc.authorscopusid7003943383
dc.authorscopusid24077472700
dc.contributor.authorBulut, O.
dc.contributor.authorPalamar, M.
dc.contributor.authorYaman, B.
dc.contributor.authorEgrilmez, S.
dc.contributor.authorYagci, A.
dc.contributor.authorBarut, Selver, O.
dc.date.accessioned2024-08-25T18:46:17Z
dc.date.available2024-08-25T18:46:17Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractPURPOSE: To define the use of human amniotic membrane transplantation (hAMT) for reconstruction of the ocular surface after ocular surface lesion excisions in pediatric population during the last decade in a tertiary eye center. METHODS: A total of 31 patients who underwent hAMT procedure because of the excision of ocular surface lesions between January 2009 and December 2021 were included in this study. The medical data were retrospectively evaluated. RESULTS: The female-to-male ratio was 14/17. The mean age of the patients was 10.1±4.1 (range, 1-18) years. Although a single hAMT was applied to most of the cases (94.4%; 34 eyes), more than one hAMT was applied to 5.6% of cases (2 eyes). The amniotic membrane degradation duration was found to be 21.5±10.8 (range, 13-50) days. CONCLUSIONS: Amniotic membrane is used as a biomaterial in various ocular surface diseases with its anti-inflammatory, antimicrobial, and wound healing properties. Although widely used, there are only a few studies reporting its clinical efficacy in the pediatric age group. It seems to be safe and effective in pediatric age group for ocular surface reconstruction after ocular surface lesion excisions. Copyright © 2023 Contact Lens Association of Ophthalmologists.en_US
dc.identifier.doi10.1097/ICL.0000000000001010
dc.identifier.endpage373en_US
dc.identifier.issn1542-233X
dc.identifier.issue9en_US
dc.identifier.pmid37395485en_US
dc.identifier.scopus2-s2.0-85168802844en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage370en_US
dc.identifier.urihttps://doi.org/10.1097/ICL.0000000000001010
dc.identifier.urihttps://hdl.handle.net/11454/101854
dc.identifier.volume49en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherNLM (Medline)en_US
dc.relation.ispartofEye & contact lensen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240825_Gen_US
dc.subjectadolescenten_US
dc.subjectamnionen_US
dc.subjectchilden_US
dc.subjecteye diseaseen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectinfanten_US
dc.subjectmaleen_US
dc.subjectpreschool childen_US
dc.subjectretrospective studyen_US
dc.subjecttransplantationen_US
dc.subjecttreatment outcomeen_US
dc.subjectwound healingen_US
dc.subjectAdolescenten_US
dc.subjectAmnionen_US
dc.subjectChilden_US
dc.subjectChild, Preschoolen_US
dc.subjectEye Diseasesen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectInfanten_US
dc.subjectMaleen_US
dc.subjectRetrospective Studiesen_US
dc.subjectTreatment Outcomeen_US
dc.subjectWound Healingen_US
dc.titleAmniotic Membrane Transplantation for Reconstruction of Ocular Surface Lesion Excisions in Pediatric Populationen_US
dc.typeArticleen_US

Dosyalar